ANGPT1 and COVID-19: Dexamethasone decreases the ratio of angiopoietin-2 to angiopoietin-1, thereby promoting endothelial stabilization and reducing endothelial cell apoptosis, which is critical in reducing mortality in critically ill COVID-19 patients [36].